Putting scientific research to better use

Plain-speaking research summaries could help the public make more informed decisions in major societal issues like COVID-19, says Charlie Rapple, co-founder of Kudos. Misinformation about science and healthcare spreads quickly – and acting on the...

Students’ discovery could help treat Alzheimer’s

Four chemistry students from the University of St Andrews have helped to discover a class of molecules that can help accelerate DNA repair which could in turn help treat of diseases such as Alzheimer’s. The...

New treatment target for neurodegenerative diseases

Long-term neurological conditions like Alzheimer’s Disease could be treated using a completely new drug strategy. Researchers at the University of Birmingham have identified a potential target for drugs to treat serious neurological conditions and foster...

New life sciences cluster in Paddington will champion health partnerships

Imperial College Healthcare NHS Trust has set out its vision for a new life sciences cluster in Paddington, founded on its growing partnerships with research, industry and community organisations around St Mary’s Hospital. The Trust...

Synthetic mouse embryo models created from stem cells

An egg meets a sperm -- the necessary first step for life and a common first step in embryonic development research. But now researchers have grown synthetic embryo models of mice outside the womb...

NETPark: the hi-tech force for growth in County Durham

NETPark of Durham provides world-class laboratory, clean room and office space to science, technology and engineering companies, ranging from start-ups to global AIM-listed firms. Managed by Business Durham and backed by on-site strategic partner CPI...

Over 1,000 genes linked to severe COVID-19

Researchers from the University of Sheffield and Stanford University in the US have discovered specific genetic signals in people who develop severe coronavirus infection. Age, body mass index and pre-existing health problems are known to...

Nanochannels light the way to new medicine

The development of new drugs and vaccines requires detailed knowledge about nature’s smallest biological building blocks – biomolecules. Swedish researchers have devised a new microscopy technique that allows proteins, DNA and other tiny biological...

Maternal microbiome promotes baby’s healthy development

Researchers studying mice have found the first evidence of how a mother’s gut microbes, the maternal microbiome, can help in the development of the placenta, and the healthy growth of the baby. Scientists from the...

A global surveillance model is vital for future pandemic prevention

Broad viral surveillance is essential in pandemic prevention to allow for detection of potential threats and the immediate early launch of health protocols against pathogens. Yves Dubaquie, senior vice president of diagnostics, PerkinElmer, Inc.,...

Unravelling the mysteries around type-2 diabetes 

Researchers at University of Leeds have pinpointed a molecule mutation that plays a key role in the disease. For more than 30 years, scientists have been trying to unravel the mystery of how a key...

Cellular protein factories may contribute to ageing and related diseases

Research finds that the cellular assembly line that produces proteins can stall with age, triggering a snowball effect that increases the output of misfolded proteins. In humans, clumps of misfolded proteins contribute to age-linked...

Potential breakthrough in treatment of rare disease

Biotech company Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the life-limiting, rare disease mucopolysaccharidosis II (MPS II) (also known as Hunter syndrome). Occurring in around 1 in...

Cancer cell ‘switch-off’ could aid deadly brain tumour treatment

Researchers believe they may have found a way to strengthen possible treatments for glioblastoma and reduce the speed at which the aggressive tumour progresses. Glioblastoma is the most common primary brain tumour in adults, and,...

Closing the Loop on personalised healthcare

Precision medicine using personalised treatments has entered mainstream healthcare. Closed Loop Medicine Ltd aims to level the playing field further with its drug and digital combination products. The Cambridge-based healthcare company is developing drug and...

Acesis breaks new ground with novel therapy solution to low testosterone

For the first time in over 70 years, a new testosterone replacement therapy has been unveiled. Dr Vassilios Papadopoulos and Dr Costas Karatzas, co-founders of Acesis BioMed, explain how their ‘first-in-class’ peptide therapeutics could...